Form 4: Arrow Financial Corp Director Gary C Dake Reports Acquisition of Common Stock
SEC Form 4
Director Gary C Dake reports acquisition of 412 shares of Arrow Financial Corp common stock and discloses holdings including shares acquired under the company's DRIP.
Summary
- On May 29, 2024, Gary C Dake, a director of Arrow Financial Corp, acquired 412 shares of common stock.
- These shares were acquired at a price of $0.
- The acquisition was part of a restricted stock grant that vests 25% per year starting May 29, 2025, and continuing on May 29, 2026, May 29, 2027, and May 29, 2028.
- Dake also reported owning 59,267 shares of common stock following the reported transaction.
- This number includes 634 shares acquired under the Company's DRIP since April 10, 2024, which were not required to be reported on a Form 4.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing. The director's acquisition of shares is mildly positive, suggesting confidence, but it's not a major event.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock indicates a multi-year commitment.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock.
Stakeholder Impact
- The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/10/2024 | Date from which 634 shares were acquired under the Company's DRIP. |
| 05/29/2024 | Date of the transaction where 412 shares of common stock were acquired. |
| 05/29/2025 | First vesting date for the restricted stock (25%). |
| 05/29/2026 | Second vesting date for the restricted stock (25%). |
| 05/29/2027 | Third vesting date for the restricted stock (25%). |
| 05/29/2028 | Final vesting date for the restricted stock (25%). |
| 05/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.